Study of Fampridine-SR Tablets in Multiple Sclerosis Patients
Status:
Completed
Trial end date:
2008-05-01
Target enrollment:
Participant gender:
Summary
The purpose of the study is to show that individuals treated with Fampridine-SR tablets are
significantly more likely to have consistent improvements in their walking than those treated
with placebo tablets.